BERTOLOTTI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.412
AS - Asia 13.118
EU - Europa 12.823
SA - Sud America 1.877
Continente sconosciuto - Info sul continente non disponibili 360
AF - Africa 271
OC - Oceania 33
Totale 60.894
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.579
SG - Singapore 4.152
IT - Italia 3.862
CN - Cina 3.511
GB - Regno Unito 3.170
HK - Hong Kong 1.574
BR - Brasile 1.406
VN - Vietnam 1.232
DE - Germania 1.040
SE - Svezia 957
FI - Finlandia 783
BD - Bangladesh 634
UA - Ucraina 593
FR - Francia 545
RU - Federazione Russa 489
TR - Turchia 484
CA - Canada 465
PL - Polonia 391
KR - Corea 328
IN - India 251
BG - Bulgaria 228
NL - Olanda 223
ID - Indonesia 171
AR - Argentina 170
JP - Giappone 108
IQ - Iraq 104
MX - Messico 96
ES - Italia 93
IE - Irlanda 81
EC - Ecuador 72
PK - Pakistan 63
ZA - Sudafrica 61
CO - Colombia 56
BE - Belgio 54
AE - Emirati Arabi Uniti 53
VE - Venezuela 53
MY - Malesia 52
AT - Austria 51
MA - Marocco 50
CR - Costa Rica 49
CL - Cile 46
PH - Filippine 45
UZ - Uzbekistan 43
TW - Taiwan 42
CH - Svizzera 39
SA - Arabia Saudita 36
CZ - Repubblica Ceca 33
IL - Israele 33
JM - Giamaica 33
HN - Honduras 32
IR - Iran 29
AU - Australia 27
LT - Lituania 27
TT - Trinidad e Tobago 27
PE - Perù 26
JO - Giordania 25
TH - Thailandia 25
ET - Etiopia 24
EG - Egitto 23
DZ - Algeria 22
PY - Paraguay 21
GT - Guatemala 20
CW - ???statistics.table.value.countryCode.CW??? 19
GR - Grecia 19
NI - Nicaragua 19
RO - Romania 19
SV - El Salvador 19
TN - Tunisia 19
KE - Kenya 17
PR - Porto Rico 17
GP - Guadalupe 16
UY - Uruguay 16
NP - Nepal 15
OM - Oman 15
SC - Seychelles 15
PT - Portogallo 13
PA - Panama 12
AZ - Azerbaigian 11
BY - Bielorussia 11
SI - Slovenia 11
BO - Bolivia 10
DK - Danimarca 9
MK - Macedonia 9
NG - Nigeria 9
RS - Serbia 9
DO - Repubblica Dominicana 8
EU - Europa 8
PS - Palestinian Territory 8
SK - Slovacchia (Repubblica Slovacca) 8
SY - Repubblica araba siriana 8
AL - Albania 7
AM - Armenia 7
BH - Bahrain 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LU - Lussemburgo 7
MD - Moldavia 7
BA - Bosnia-Erzegovina 6
EE - Estonia 6
HU - Ungheria 6
Totale 60.448
Salva come PNG Salva come JPEG
Città #
Ashburn 4.360
Singapore 2.791
Santa Clara 2.499
Fairfield 2.380
Southend 2.013
Hong Kong 1.550
Woodbridge 1.496
San Jose 1.413
Houston 1.329
Chandler 1.322
Jacksonville 1.046
Hefei 984
Seattle 899
Dearborn 830
Wilmington 828
Ann Arbor 820
Council Bluffs 819
Cambridge 788
Beijing 637
Chicago 590
Helsinki 577
London 577
Nyköping 571
Los Angeles 570
Ho Chi Minh City 404
Modena 389
New York 383
Warsaw 372
Milan 340
Seoul 315
The Dalles 311
San Diego 302
Hanoi 281
Izmir 278
Princeton 253
Sofia 216
São Paulo 209
Salt Lake City 199
Buffalo 188
Boardman 187
Eugene 187
Lauterbourg 186
Rome 183
Shanghai 165
Columbus 160
Toronto 160
Dallas 145
Moscow 143
Munich 131
Bologna 126
Tampa 118
Des Moines 112
Elk Grove Village 112
Jakarta 104
Orem 85
Fremont 83
North Bergen 83
Washington 82
Tokyo 80
Phoenix 79
Frankfurt am Main 78
Redwood City 76
Guangzhou 71
Montreal 67
Brooklyn 65
Dublin 64
Haiphong 62
Denver 60
Atlanta 58
Naples 58
Bremen 57
Grafing 57
Da Nang 55
Falls Church 54
Sterling 53
Florence 51
San Francisco 50
Baghdad 49
Brussels 44
Parma 44
Turin 44
North York 43
Miami 42
Lancaster 40
Turku 40
Boston 39
San Mateo 39
Manchester 38
Nuremberg 38
Amsterdam 37
Mountain View 35
Chennai 34
Kunming 34
Norwalk 34
Tashkent 34
Kent 33
San José 33
Charlotte 32
Mexico City 32
Nanjing 32
Totale 40.746
Salva come PNG Salva come JPEG
Nome #
MoCA 7.1: Multicenter Validation of the First Italian Version of Montreal Cognitive Assessment 1.261
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 746
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 553
17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures 494
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 484
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 467
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 457
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 453
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 443
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 434
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 427
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 418
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY 418
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 410
Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study 402
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 402
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 400
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 400
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 397
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 393
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 390
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 388
Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy 385
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 383
Effects of cholecalciferol supplementation in patients with stable heart failure and low vitamin D levels (ECSPLOIT-D). A double-blind, randomized, placebo-controlled pilot study 382
Physical exercise for late life depression: effects on cognition and disability 380
Serum time course of naltrexone and 6 beta-naltrexol levels during long term treatment in drug addicts 378
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 375
La clinica metabolica per il trattamento della lipodistrofia 375
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 374
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 371
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 368
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 365
Telomere length elongation after weight loss intervention in obese adults 364
The relationship between age and fat infiltration in liver and muscle 362
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 361
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 361
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 360
Predictive factors of lack of response to antiviral therapy among in patients with recurrent hepatitis C after liver transplantation. 360
Endocrine and liver interaction: the role of endocrine pathways in NASH 359
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 353
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study 351
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 351
Novel genetic mutation in apolipoprotein E2 homozygosis and its implication in organ donation: a case report 350
Short-term effects of simvastatin on bile acid synthesis and biliary lipid secretion in human subjects. 349
Bile acids and nonalcoholic fatty liver disease: An intriguing relationship 348
Analgesic drug taking: Beliefs and behavior among headache patients 348
Nonalcoholic fatty liver disease and aging: epidemiology to management 346
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 340
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 336
Anatomia e fisiologia delle vie biliari 330
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e 329
Il pool degli acidi biliari quale regolatore del metabolismo epatico del colesterolo: sintesi degli acidi biliari. 328
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 326
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 326
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 323
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 323
Risk of birth defects associated with maternal pregestational diabetes. 321
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 317
Review article: effect of bile salt pool composition on hepatic and biliary functions 316
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 316
Disposition of naproxen after oral administration during and between migraine attacks. 315
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 315
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 314
Associated factors to post-operative delirium in patients with hip fractures: an orthogeriatric experience. 313
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 309
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 308
Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials 308
Advances in the comprehension of the pathophysiology of bile secretion 305
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 302
Liver X receptors and copper metabolism: New frontiers for the oxysterol receptors 302
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 302
Effects of acute changes of bile acid pool composition on biliary lipid secretion 300
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 300
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 299
Effect of ursocholic acid on bile lipid secretion and composition 296
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 296
Bile acid structure and regulation of biliary protein secretion and composition in man 294
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 294
Naltrexone: aspetti di farmacologia ed applicazioni cliniche 293
Olanzapine metabolic side effects: a weight gain issue? 291
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 290
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 290
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 284
Nuclear receptors and obstructive cholestasis in Humans: increased heaptic expression of short heterodimer partner : a protective response? 283
Case of an old man with aortic dissection type A and enlarging meningioma 283
Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular Prevention 282
Drug metabolism in liver cirrhosis: alterations of the time-course of plasma naltrexone levels after oral intake 280
The use of stable and radioactive sterol tracers as a tool to investigate cholesterol degradation to bile acids in humans in vivo 278
Nonalcoholic fatty liver disease induced by leuprorelin acetate 278
REGULATION OF HEPATIC CHOLESTEROL-METABOLISM IN THE RAT IN-VIVO. EFFECT OF A SYNTHETIC FAT-FREE DIET ON STEROL SYNTHESIS AND LOW-DENSITY-LIPOPROTEIN TRANSPORT 277
Patogenesi della colelitiasi. I. Colelitiasi colesterinica. 276
Pharmacological outline of chronic headache patients: overlap between depressive and nociceptive symptomatology 276
Risk communication at the time of Coronavirus: are we washing our hand of COVID-19? 276
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 274
Hypertensive disease in the elderly: Predictors of clinical evolution in a follow-up study 274
Review article: hyperlipidaemia and cardiovascular risk 272
Bleeding jejunal varices and portal thrombosis in a splenectomized patient with hereditary spherocytosis 270
Instrumental assessment of balance and gait in depression: A systematic review 269
PHARMACOKINETICS OF TIAPROFENIC ACID AFTER ORAL-ADMINISTRATION IN FASTING PATIENTS DURING AND BETWEEN MIGRAINE ATTACKS 267
Totale 35.662
Salva come PNG Salva come JPEG
Categoria #
all - tutte 230.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 230.006
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.015 0 0 0 0 101 218 314 266 552 243 808 513
2022/20233.991 417 361 312 350 448 576 102 430 510 74 218 193
2023/20242.853 128 163 184 271 527 231 366 339 103 111 135 295
2024/20258.969 320 152 215 638 1.816 1.277 587 444 876 449 972 1.223
2025/202618.278 996 697 1.426 2.152 3.209 1.669 1.946 842 1.671 1.423 1.316 931
2026/20276.786 656 1.172 1.654 2.987 317 0 0 0 0 0 0 0
Totale 60.894